100 Participants NeededMy employer runs this trial

Imaging Techniques for Alcoholism

RN
Overseen ByRajesh Narendran
Age: 18 - 65
Sex: Any
Trial Phase: Phase < 1
Sponsor: Rajesh Narendran
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

Studies proposed in this application will image mitochondrial Complex-I (MCI-I) and cerebral glucose metabolism (CGM) in alcohol use disorder (AUD) and matched healthy controls

Who Is on the Research Team?

RN

Rajesh Narendran, MD

Principal Investigator

University of Pittsburgh

Are You a Good Fit for This Trial?

This trial is for adults with alcohol use disorder (problem drinking or alcoholism) as well as healthy individuals to serve as a comparison group. Participants must be able to safely undergo brain imaging scans.

Inclusion Criteria

Healthy controls (HC): No history of heavy drinking as defined using NIAAA criteria in the past year
Alcohol use disorders (AUD): Fulfill DSM-5 criteria for alcohol use disorder
Alcohol use disorders (AUD): History of NIAAA heavy drinking in the past 30 days (males: >4 drinks any day or >14 drinks per week; females: >3 drinks any day or >7 drinks per week)
See 3 more

Exclusion Criteria

I have not worked with radiation or joined radiation studies in the past year above safe limits.
Alcohol use disorders (AUD): No other major DSM-5 psychiatric disorders including schizophrenia, schizoaffective disorder, bipolar disorder, developmental disorders, or current depressive disorders unless related to alcohol intoxication, withdrawal, or alcohol-induced mood disorder
Alcohol use disorders (AUD): No other DSM-5 substance use disorders including opioids, cocaine, amphetamines, sedative-hypnotics, hallucinogens, inhalants; moderate and severe DSM-5 cannabis and tobacco use disorder excluded
See 5 more

What Are the Treatments Tested in This Trial?

Interventions

  • [F-18]BCPP-EF
  • [F-18]FDG

Trial Overview

The study uses special PET scans with two tracers, [F-18]BCPP-EF and [F-18]FDG, to look at how the brain's energy systems work in people with alcohol use disorder compared to healthy controls.

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: PETExperimental Treatment2 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

Rajesh Narendran

Lead Sponsor

Trials
4
Recruited
180+

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Collaborator

Trials
865
Recruited
1,091,000+